James A. Karlowsky
Address correspondence to James A. Karlowsky
Name/email consistency: high
- Prevalence of Antimicrobial Resistance among Clinical Isolates of Bacteroides fragilis Group in Canada in 2010-2011: CANWARD Surveillance Study. Karlowsky, J.A., Walkty, A.J., Adam, H.J., Baxter, M.R., Hoban, D.J., Zhanel, G.G. Antimicrob. Agents Chemother. (2012)
- Antimicrobial Resistance in Urinary Tract Pathogens in Canada from 2007 to 2009: CANWARD Surveillance Study. Karlowsky, J.A., Lagacé-Wiens, P.R., Simner, P.J., Decorby, M.R., Adam, H.J., Walkty, A., Hoban, D.J., Zhanel, G.G. Antimicrob. Agents Chemother. (2011)
- In Vitro Activity of Ceftaroline against Gram-Positive and Gram-Negative Pathogens Isolated from Patients in Canadian Hospitals in 2009. Karlowsky, J.A., Adam, H.J., Decorby, M.R., Lagacé-Wiens, P.R., Hoban, D.J., Zhanel, G.G. Antimicrob. Agents Chemother. (2011)
- In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study. Karlowsky, J.A., Adam, H.J., Poutanen, S.M., Hoban, D.J., Zhanel, G.G. Diagn. Microbiol. Infect. Dis. (2011)
- AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity. Karlowsky, J.A., Kaplan, N., Hafkin, B., Hoban, D.J., Zhanel, G.G. Antimicrob. Agents Chemother. (2009)
- Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005. Karlowsky, J.A., Lagacé-Wiens, P.R., Low, D.E., Zhanel, G.G. Int. J. Antimicrob. Agents (2009)
- In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile. Karlowsky, J.A., Laing, N.M., Zhanel, G.G. Antimicrob. Agents Chemother. (2008)
- Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimens. Karlowsky, J.A., Kasloff, S., Nichol, K.A., Hoban, D.J., Zhanel, G.G. Diagn. Microbiol. Infect. Dis. (2007)
- In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species. Karlowsky, J.A., Hoban, D.J., Zhanel, G.G., Goldstein, B.P. Int. J. Antimicrob. Agents (2006)
- Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Karlowsky, J.A., Hoban, D.J., Decorby, M.R., Laing, N.M., Zhanel, G.G. Antimicrob. Agents Chemother. (2006)
- Presence of ROB-1 beta-lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influenzae. Karlowsky, J.A., Verma, G., Zhanel, G.G., Hoban, D.J. J. Antimicrob. Chemother. (2000)